**Core Concept**
The question is testing the student's knowledge of protease inhibitors, a class of drugs that inhibit the action of proteases, enzymes that break down proteins. In the context of antiviral therapy, protease inhibitors are used to treat viral infections such as HIV and hepatitis C.

**Why the Correct Answer is Right**
Protease inhibitors work by binding to the protease enzyme, preventing it from cleaving viral proteins necessary for viral replication. This is crucial in the life cycle of viruses like HIV, which relies on protease to mature and produce infectious particles. By inhibiting protease, these drugs effectively block the virus's ability to replicate and spread.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not mention a specific drug class that inhibits proteases. While some antiviral drugs may have protease-inhibiting activity, they are not classified as protease inhibitors.
**Option B:** This option is incorrect because it refers to a class of drugs that inhibit nucleoside analogs, not proteases. Nucleoside analogs work by incorporating into viral DNA or RNA, disrupting viral replication.
**Option C:** This option is incorrect because it refers to a class of drugs that inhibit integrase, another enzyme critical in the HIV life cycle. Integrase inhibitors prevent the integration of viral DNA into the host genome, but they do not inhibit proteases.

**Clinical Pearl / High-Yield Fact**
When selecting an antiviral therapy regimen, it is essential to consider the specific mechanism of action and resistance profile of each drug. Protease inhibitors can be used in combination with other antiretroviral drugs to achieve optimal viral suppression and prevent the development of resistance.

**Correct Answer: C. Ritonavir**